Although ADAM17 exerts potential regulatory effects in cardiovascular diseases, including cardiac hypertrophy, coronary microvascular dysfunction, and thoracic aortic aneurysm [12, 13, 15, 38–40], its precise function in cardiac fibrosis remains unknown. The gene discussed is ADAM17; the disease is thoracic aortic aneurysm.